Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Hamadani

Showing results (91-100 of 460) with videos related to

Pageof 46
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2017
Systemic Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma: A Population-based Analysis of Incidence and SurvivalGuru Subramanian Guru Murthy, Mehdi Hamadani, Vijaya Raj Bhatt, et al.
Blood Advances|November 23, 2022
Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapyFateeha Furqan, Morgan Maring, Aniko Szabo, et al.
The Oncologist|August 31, 2019
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results DatabaseGuru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, et al.
Hematology/Oncology and Stem Cell Therapy|August 5, 2021
The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic LeukemiaKhalid Halahleh, Dalia Al Rimawi, Amal Abu Ghosh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2013
Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantationMohamed A Kharfan-Dabaja, Hillard M Lazarus, Taiga Nishihori, et al.
British Journal of Haematology|May 17, 2020
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expressionTalha Badar, John Astle, Imran K Kakar, et al.
Bone Marrow Research|May 22, 2013
Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte GlobulinLauren Veltri, Michael Regier, Aaron Cumpston, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2013
Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remissionQuoc Truong, Nilay Shah, Mark Knestrick, et al.
Best Practice & Research. Clinical Haematology|October 16, 2016
Current state of hematopoietic cell transplantation in CLL as smart therapies emergeMohamed A Kharfan-Dabaja, Jessica El-Asmar, Farrukh T Awan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2020
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?Peter Dreger, Timothy S Fenske, Silvia Montoto, et al.
Pageof 46

Showing results (91-100 of 460) with videos related to

Sort By:
Pageof 46
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2017
Systemic Anaplastic Lymphoma Kinase-positive Anaplastic Large Cell Lymphoma: A Population-based Analysis of Incidence and SurvivalGuru Subramanian Guru Murthy, Mehdi Hamadani, Vijaya Raj Bhatt, et al.
Blood Advances|November 23, 2022
Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapyFateeha Furqan, Morgan Maring, Aniko Szabo, et al.
The Oncologist|August 31, 2019
Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results DatabaseGuru Subramanian Guru Murthy, Aniko Szabo, Mehdi Hamadani, et al.
Hematology/Oncology and Stem Cell Therapy|August 5, 2021
The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic LeukemiaKhalid Halahleh, Dalia Al Rimawi, Amal Abu Ghosh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2013
Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantationMohamed A Kharfan-Dabaja, Hillard M Lazarus, Taiga Nishihori, et al.
British Journal of Haematology|May 17, 2020
Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expressionTalha Badar, John Astle, Imran K Kakar, et al.
Bone Marrow Research|May 22, 2013
Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte GlobulinLauren Veltri, Michael Regier, Aaron Cumpston, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 15, 2013
Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remissionQuoc Truong, Nilay Shah, Mark Knestrick, et al.
Best Practice & Research. Clinical Haematology|October 16, 2016
Current state of hematopoietic cell transplantation in CLL as smart therapies emergeMohamed A Kharfan-Dabaja, Jessica El-Asmar, Farrukh T Awan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2020
Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?Peter Dreger, Timothy S Fenske, Silvia Montoto, et al.
Pageof 46